144 related articles for article (PubMed ID: 6783669)
41. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
Amacher DE; Paillet S; Ray VA
Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
[TBL] [Abstract][Full Text] [Related]
42. The ability of the mouse lymphoma TK assay to detect aneugens.
Fellows MD; Doherty AT; Priestley CC; Howarth V; O'Donovan MR
Mutagenesis; 2011 Nov; 26(6):771-81. PubMed ID: 21775299
[TBL] [Abstract][Full Text] [Related]
43. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
44. NTP Toxicology and Carcinogenesis Studies of Iodinated Glycerol (Organidin(R).) (CAS No. 5634-39-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1990 Mar; 340():1-171. PubMed ID: 12724785
[TBL] [Abstract][Full Text] [Related]
45. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
46. NTP Toxicology and Carcinogenesis Studies of d-Limonene (CAS No. 5989-27-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1990 Jan; 347():1-165. PubMed ID: 12704437
[TBL] [Abstract][Full Text] [Related]
47. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
48. Methyl methanesulphonate mutagenesis in L5178Y mouse lymphoma cells.
Cole J; Arlett CF
Mutat Res; 1978 Apr; 50(1):111-20. PubMed ID: 205781
[TBL] [Abstract][Full Text] [Related]
49. Colony morphology and heritability of anchorage-independent growth among spontaneously transformed Balb/3T3 cells.
Rubin H; Romerdahl CA; Chu BM
J Natl Cancer Inst; 1983 Jun; 70(6):1087-96. PubMed ID: 6190034
[TBL] [Abstract][Full Text] [Related]
50. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
51. Effect of pH shifts on the mutant frequency at the thymidine kinase locus in mouse lymphoma L5178Y TK+/- cells.
Cifone MA; Myhr B; Eiche A; Bolcsfoldi G
Mutat Res; 1987 Sep; 189(1):39-46. PubMed ID: 3114628
[TBL] [Abstract][Full Text] [Related]
52. NTP Toxicology and Carcinogenesis Studies of Hydroquinone (CAS No. 123-31-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Oct; 366():1-248. PubMed ID: 12692638
[TBL] [Abstract][Full Text] [Related]
53. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
[TBL] [Abstract][Full Text] [Related]
54. Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 May; 356():1-190. PubMed ID: 12695785
[TBL] [Abstract][Full Text] [Related]
55. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
McGregor DB; Brown AG; Cattanach P; Shepherd W; Riach C; Daston DS; Caspary WJ
Carcinogenesis; 1989 Nov; 10(11):2003-8. PubMed ID: 2478309
[TBL] [Abstract][Full Text] [Related]
56. The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk +/- 3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei.
Cole J; Richmond FN; Bridges BA
Mutat Res; 1991 Aug; 253(1):55-62. PubMed ID: 1908053
[TBL] [Abstract][Full Text] [Related]
57. Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleoside transporter expression or increased secretory phospholipase A2.
Temmink OH; Bijnsdorp IV; Prins HJ; Losekoot N; Adema AD; Smid K; Honeywell RJ; Ylstra B; Eijk PP; Fukushima M; Peters GJ
Mol Cancer Ther; 2010 Apr; 9(4):1047-57. PubMed ID: 20371715
[TBL] [Abstract][Full Text] [Related]
58. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
[TBL] [Abstract][Full Text] [Related]
59. [Mutational spectra in the tk gene of mouse lymphoma cells induced by acrylamide].
Yuan J; Liu SX; Liu JY; Cao J
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Apr; 23(2):125-8. PubMed ID: 16105457
[TBL] [Abstract][Full Text] [Related]
60. Mutagenicity of the mycotoxin alternariol in cultured mammalian cells.
Brugger EM; Wagner J; Schumacher DM; Koch K; Podlech J; Metzler M; Lehmann L
Toxicol Lett; 2006 Jul; 164(3):221-30. PubMed ID: 16464542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
